Equities

Santen Pharmaceutical Co Ltd

Santen Pharmaceutical Co Ltd

Actions
  • Price (USD)11.21
  • Today's Change0.00 / 0.00%
  • Shares traded1.00
  • 1 Year change+17.53%
  • Beta--
Data delayed at least 15 minutes, as of Sep 18 2024 16:25 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Dividends in JPY

Historical dividend information is not available for Santen Pharmaceutical Co Ltd.
Div growth (TTM)3.13%
More ▼

Earnings history & estimates in JPY

On Aug 06, 2024, Santen Pharmaceutical Co Ltd reported 1st quarter 2025 earnings of 29.59 per share. This result exceeded the 24.00 expectation of the one analyst covering the company and exceeded last year's 1st quarter results by 5.94%.
The next earnings announcement is expected on Nov 05, 2024.
Average growth rate+2,184.60%
Santen Pharmaceutical Co Ltd reported annual 2024 earnings of 72.59 per share on May 09, 2024.
Average growth rate+113.62%
More ▼

Revenue history & estimates in JPY

-32768 had 1st quarter 2025 revenues of 74.77m. This bettered the 70.50m estimate of the one analyst covering the company. This was 3.29% above the prior year's 1st quarter results.
Average growth rate+0.89%
-32768 had revenues for the full year 2024 of 301.97m. This was 8.22% above the prior year's results.
Average growth rate+5.76%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.